CNPY2 governs PDGF‑BB‑treated vascular smooth muscle cell proliferation, migration and phenotypic transformation via the Akt/mTOR/GSK‑3β signaling pathway

Sun,Houqi; Wang,Xuejie; Ma,Ling; Li,Xu; Jin,Wenjing; Yang,Yongbin

doi:10.3892/etm.2024.12485

CNPY2 governs PDGF‑BB‑treated vascular smooth muscle cell proliferation, migration and phenotypic transformation via the Akt/mTOR/GSK‑3β signaling pathway

Authors:
- Houqi Sun
- Xuejie Wang
- Ling Ma
- Xu Li
- Wenjing Jin
- Yongbin Yang
View Affiliations

Affiliations: Department of Interventional Medicine, Bazhou People's Hospital, Korla, Xinjiang 841000, P.R. China, Department of Hypertension, Bazhou People's Hospital, Korla, Xinjiang 841000, P.R. China, Department of General Medicine, Bazhou People's Hospital, Korla, Xinjiang 841000, P.R. China, Department of General Surgery, Bazhou People's Hospital, Korla, Xinjiang 841000, P.R. China, Department of Medical Imaging, Bazhou People's Hospital, Korla, Xinjiang 841000, P.R. China
Published online on: March 12, 2024 https://doi.org/10.3892/etm.2024.12485
Article Number: 197
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Phenotype switching of vascular smooth muscle cells (VSMCs) is a pathological process in various vascular diseases. Canopy FGF signaling regulator 2 (CNPY2) has previously been found to be abnormally expressed in ApoE‑/‑ mice and aortic endothelial cells, indicating it may have an important role in vascular diseases. The present study aimed to determine the role and mechanism of CNPY2 in VSMC phenotype switching. Following stimulation with platelet‑derived growth factor type BB (PDGF‑BB), the expression of CNPY2 in VSMCs was detected using reverse transcription‑quantitative PCR and western blot analysis. Subsequently, to explore the regulatory effects of CNPY2 on VSMCs, CNPY2 expression was knocked down by transfection with short hairpin RNA and cell viability, proliferation, migration and phenotypic transformation indicators were detected. Western blot analysis was also used to detect the phosphorylation of Akt/mTOR/GSK‑3β pathway‑associated proteins downstream of CNPY2. In addition, pretreatment with the Akt pathway activator SC79 was performed to further explore the regulatory mechanisms of CNPY2. The results revealed that CNPY2 expression was upregulated in PDGF‑BB‑stimulated VSMCs. In addition, the knockdown of CNPY2 inhibited PDGF‑BB‑induced VSMC hyperproliferation, cell cycle arrest, migration and phenotypic transformation, as well the activation of Akt/mTOR/GSK‑3β pathway‑associated proteins. Pretreatment with SC79 significantly reversed the inhibitory effects of CNPY2 knockdown on the proliferation, cell cycle arrest, migration and phenotypic transformation of the model cells. In summary, the present study indicates that CNPY2 regulates the abnormal proliferation, migration and phenotypic transformation of PDGF‑BB‑stimulated VSMCs via activation of the Akt/mTOR/GSK‑3β signaling pathway.

View Figures

View References

1	Hutchings G, Kruszyna Ł, Nawrocki MJ, Strauss E, Bryl R, Spaczyńska J, Perek B, Jemielity M, Mozdziak P, Kempisty B, et al: Molecular mechanisms associated with ROS-dependent angiogenesis in lower extremity artery disease. Antioxidants (Basel. 10(735)2021.PubMed/NCBI View Article : Google Scholar
2	Grover SP and Mackman N: Tissue factor in atherosclerosis and atherothrombosis. Atherosclerosis. 307:80–86. 2020.PubMed/NCBI View Article : Google Scholar
3	Zhang R, Lai ZC and Liu CW: Femoral-popliteal arteriosclerosis obliterans:Review of evidence-based studies on drug-eluting endovascular treatment. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 41:256–260. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
4	Schicho A, Bäumler W, Verloh N, Beyer LP, Schierling W, Uller W, Gößmann H, Stroszczynski C and Dollinger M: Percutaneous aspiration thrombectomy for arterial thromboembolic occlusion following percutaneous transluminal angioplasty: Technical success rates and clinical outcomes. Rofo. 194:291–295. 2022.PubMed/NCBI View Article : Google Scholar
5	Machado M, Borges de Almeida G, Sequeira M, Pedro F, Fior A, Carvalho R, Fragata I, Reis J and Nunes AP: Percutaneous transluminal angioplasty and stenting in acute stroke caused by basilar artery steno-occlusive disease: The experience of a single stroke centre. Interv Neuroradiol. 28:547–555. 2022.PubMed/NCBI View Article : Google Scholar
6	Cao G, Xuan X, Hu J, Zhang R, Jin H and Dong H: How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal. 20(180)2022.PubMed/NCBI View Article : Google Scholar
7	Petsophonsakul P, Furmanik M, Forsythe R, Dweck M, Schurink GW, Natour E, Reutelingsperger C, Jacobs M, Mees B and Schurgers L: Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 39:1351–1368. 2019.PubMed/NCBI View Article : Google Scholar
8	Zhang L, Tao Y, Yang R, Hu Q, Jia J, Yu M, He B, Shen Z, Qin H, Yu Z and Chen P: Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway. Phytomedicine. 107(154450)2022.PubMed/NCBI View Article : Google Scholar
9	Green ID, Liu R and Wong JJL: The expanding role of alternative splicing in vascular smooth muscle cell plasticity. Int J Mol Sci. 22(10213)2021.PubMed/NCBI View Article : Google Scholar
10	Zhang F, Guo X, Xia Y and Mao L: An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis. Cell Mol Life Sci. 79(6)2021.PubMed/NCBI View Article : Google Scholar
11	Wang G, Luo Y, Gao X, Liang Y, Yang F, Wu J, Fang D and Luo M: MicroRNA regulation of phenotypic transformations in vascular smooth muscle: Relevance to vascular remodeling. Cell Mol Life Sci. 80(144)2023.PubMed/NCBI View Article : Google Scholar
12	Medrano-Bosch M, Simón-Codina B, Jiménez W, Edelman ER and Melgar-Lesmes P: Monocyte-endothelial cell interactions in vascular and tissue remodeling. Front Immunol. 14(1196033)2023.PubMed/NCBI View Article : Google Scholar
13	Holycross BJ, Blank RS, Thompson MM, Peach MJ and Owens GK: Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res. 71:1525–1532. 1992.PubMed/NCBI View Article : Google Scholar
14	Chen PY, Qin L, Li G, Tellides G and Simons M: Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGFβ)-dependent smooth muscle cell phenotype modulation. Sci Rep. 6(33407)2016.PubMed/NCBI View Article : Google Scholar
15	Chen KQ, Zhang YQ, Wang ZB and Wang SZ: Progress in research on CNPY2 in diseases. Mini Rev Med Chem. 24:391–402. 2024.PubMed/NCBI View Article : Google Scholar
16	Huang H, Tang N, Li Y, Huo Q, Chen Q and Meng Q: The role of CNPY2 in endothelial injury and inflammation during the progress of atherosclerosis. J Mol Histol. 54:195–205. 2023.PubMed/NCBI View Article : Google Scholar
17	Guo J, Zhang Y, Mihic A, Li SH, Sun Z, Shao Z, Wu J, Weisel RD and Li RK: A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation. Cardiovasc Res. 105:383–393. 2015.PubMed/NCBI View Article : Google Scholar
18	Weyand CM and Goronzy JJ: Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med. 69 (Suppl 2):SII28–SII32. 2002.PubMed/NCBI View Article : Google Scholar
19	Xu TY, Qing SL, Zhao JX, Song J, Miao ZW, Li JX, Yang FY, Zhao HY, Zheng SL, Li ZY, et al: Metrnl deficiency retards skin wound healing in mice by inhibiting AKT/eNOS signaling and angiogenesis. Acta Pharmacol Sin. 44:1790–1800. 2023.PubMed/NCBI View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
21	Zhao MJ, Jiang HR, Sun JW, Wang ZA, Hu B, Zhu CR, Yin XH, Chen MM, Ma XC, Zhao WD and Luan ZG: Roles of RAGE/ROCK1 pathway in HMGB1-induced early changes in barrier permeability of human pulmonary microvascular endothelial cell. Front Immunol. 12(697071)2021.PubMed/NCBI View Article : Google Scholar
22	Zhou J, Jiang YY, Chen H, Wu YC and Zhang L: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Cell Prolif. 53(e12739)2020.PubMed/NCBI View Article : Google Scholar
23	Gao Q, Chen K, Gao L, Zheng Y and Yang YG: Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells. Cell Death Dis. 7(e2368)2016.PubMed/NCBI View Article : Google Scholar
24	Zhang Q, Lu S, Li T, Yu L, Zhang Y, Zeng H, Qian X, Bi J and Lin Y: ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. J Exp Clin Cancer Res. 38(173)2019.PubMed/NCBI View Article : Google Scholar
25	Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A and Hill BG: PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J. 451:375–388. 2013.PubMed/NCBI View Article : Google Scholar
26	Liu YX, Yuan PZ, Wu JH and Hu B: Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis. J Mol Med (Berl). 99:1511–1526. 2021.PubMed/NCBI View Article : Google Scholar
27	Yin W, Guo J, Zhang C, Alibhai FJ, Li SH, Billia P, Wu J, Yau TM, Weisel RD and Li RK: Knockout of canopy 2 activates p16^INK4a pathway to impair cardiac repair. J Mol Cell Cardiol. 132:36–48. 2019.PubMed/NCBI View Article : Google Scholar
28	Tian T, Dong Y, Zhu Y, Chen Y, Li X, Kuang Q, Liu X, Li P, Li J and Zhou L: Hypoxia-induced CNPY2 upregulation promotes glycolysis in cervical cancer through activation of AKT pathway. Biochem Biophys Res Commun. 551:63–70. 2021.PubMed/NCBI View Article : Google Scholar
29	Dou Y, Lei JQ, Guo SL, Zhao D, Yue HM and Yu Q: The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3β pathway in non-small cell lung cancer. Cell Biol Int. 42:959–964. 2018.PubMed/NCBI View Article : Google Scholar
30	Huang S, Xu T, Huang X, Li S, Qin W, Chen W and Zhang Z: miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways. Arch Med Sci. 15:1490–1497. 2019.PubMed/NCBI View Article : Google Scholar
31	Dong J, Lin J, Wang B, He S, Wu C, Kushwaha KK, Mohabeer N, Su Y, Fang H, Huang K and Li D: Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway. Cell Physiol Biochem. 35:160–174. 2015.PubMed/NCBI View Article : Google Scholar
32	Tang Z, Shi H, Chen C, Teng J, Dai J, Ouyang X, Liu H, Hu Q, Cheng X, Ye J, et al: Activation of platelet mTORC2/Akt pathway by anti-β2GP1 antibody promotes thrombosis in antiphospholipid syndrome. Arterioscler Thromb Vasc Biol. 43:1818–1832. 2023.PubMed/NCBI View Article : Google Scholar